These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Immunotherapy using IL-6 receptor as the target]. Nishimoto N Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):399-404. PubMed ID: 18974624 [TBL] [Abstract][Full Text] [Related]
3. Discovery of IL-6 and Development of Anti-IL-6R Antibody. Kishimoto T Keio J Med; 2019; 68(4):96. PubMed ID: 31875623 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacological and clinical profile of anti-human IL-6 receptor antibody (tocilizumab, ACTEMRA), a novel therapeutic drug for Castleman's disease]. Ohsugi Y; Tsuchimoto N Nihon Yakurigaku Zasshi; 2005 Dec; 126(6):419-25. PubMed ID: 16462093 [No Abstract] [Full Text] [Related]
15. Anti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases. Ding C; Jones G Rev Recent Clin Trials; 2006 Sep; 1(3):193-200. PubMed ID: 18473972 [TBL] [Abstract][Full Text] [Related]
16. Inhibiting interleukin-6 in rheumatoid arthritis. Choy E Curr Rheumatol Rep; 2008 Oct; 10(5):413-7. PubMed ID: 18817647 [TBL] [Abstract][Full Text] [Related]
17. [New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)]. Nasonov EL Ter Arkh; 2010; 82(5):64-71. PubMed ID: 20597275 [TBL] [Abstract][Full Text] [Related]